Publicaciones en las que colabora con María del Carmen Arufe Gonda (17)

2018

  1. The addition of albumin improves Schwann cells viability in nerve cryopreservation

    Cell and Tissue Banking, Vol. 19, Núm. 4, pp. 507-517

2017

  1. Biodistribution and immunogenicity of allogeneic mesenchymal stem cells in a rat model of intraarticular chondrocyte xenotransplantation

    Frontiers in Immunology, Vol. 8, Núm. NOV

  2. CD105+-mesenchymal stem cells migrate into osteoarthritis joint: An animal model

    PLoS ONE, Vol. 12, Núm. 11

2016

  1. 3, 3′, 5-triiodo-L-thyronine Increases In Vitro Chondrogenesis of Mesenchymal Stem Cells From Human Umbilical Cord Stroma Through SRC2

    Journal of Cellular Biochemistry, pp. 2097-2108

2015

  1. iTRAQ-based analysis of progerin expression reveals mitochondrial dysfunction, reactive oxygen species accumulation and altered proteostasis

    Stem Cell Research and Therapy, Vol. 6, Núm. 1

2014

  1. Influence of flap prefabrication on seeding of subcutaneously injected mesenchymal stem cells in microvascular beds in rats

    Annals of Plastic Surgery, Vol. 73, Núm. 2, pp. 234-238

  2. Proteomic applications in the study of human mesenchymal stem cells

    Proteomes, Vol. 2, Núm. 1, pp. 53-71

2013

  1. Lamin A deregulation in human mesenchymal stem cells promotes an impairment in their chondrogenic potential and imbalance in their response to oxidative stress

    Stem Cell Research, Vol. 11, Núm. 3, pp. 1137-1148

  2. Quantitative proteomics (itraq) as a tool to understand the premature aging process in progeria

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 9, pp. 77-77

2012

  1. Proteome analysis during chondrocyte differentiation in a new chondrogenesis model using human umbilical cord stroma mesenchymal stem cells

    Molecular and Cellular Proteomics, Vol. 11, Núm. 2

2011

  1. A combination of both proteomic and genetic approach to indentify de-regulated pathway in progeria, an accelerated aging disorder

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 7, pp. 173-173

  2. Analysis of the chondrogenic potential and secretome of mesenchymal stem cells derived from human umbilical cord stroma

    Stem Cells and Development, Vol. 20, Núm. 7, pp. 1199-1212

  3. Proteome analysis during a new chondrogenesis model from mesenchymal stem cells of human umbilical cord stroma

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 7, pp. 120-120

  4. Umbilical cord as a mesenchymal stem cell source for treating joint pathologies

    World Journal of Orthopaedics, Vol. 2, Núm. 6, pp. 43-50

2010

  1. Chondrogenic potential of subpopulations of cells expressing mesenchymal stem cell markers derived from human synovial membranes

    Journal of Cellular Biochemistry, Vol. 111, Núm. 4, pp. 834-845

2009

  1. Differentiation of synovial CD-105+ human mesenchymal stem cells into chondrocyte-like cells through spheroid formation

    Journal of Cellular Biochemistry, Vol. 108, Núm. 1, pp. 145-155

2007

  1. Treatment of joint cartilage lesions with cell therapy

    Reumatologia Clinica, Vol. 3, Núm. EXTRA 3, pp. 63-69